Novartis said on Thursday it would acquire U.S.-based neuroscience company Cadent for up to $770 million, gaining full rights to Cadent's portfolio.

Nyxoah (NYXH) announced that the first U.S. commercial patients have been successfully implanted with the Genio system following FDA approval. “We are thrilled to announce that the first commercial ...

Packed with blushy, wide-eyed experimentation and a wicked willingness to play along when told what to do, this page is absolute catnip for anyone with an insistent streak. Her whole thing is fresh ...